136 related articles for article (PubMed ID: 16611270)
1. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population.
Fabrizi F; Dixit V; Bunnapradist S; Martin P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1105-12. PubMed ID: 16611270
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
Fabrizi F; Dixit V; Messa P; Martin P
Aliment Pharmacol Ther; 2010 Sep; 32(6):756-62. PubMed ID: 20662784
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.
Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Jun; 23(11):1559-66. PubMed ID: 16696803
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.
Fabrizi F; Dixit V; Martin P; Messa P
Aliment Pharmacol Ther; 2011 Apr; 33(7):815-21. PubMed ID: 21281319
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Fabrizi F; Ganeshan SV; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
Alavian SM; Tabatabaei SV
Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
[TBL] [Abstract][Full Text] [Related]
10. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin use and immunogenicity of hepatitis B virus vaccine in chronic kidney disease patients: a meta-analysis.
Fabrizi F; Dixit V; Martin P; Messa P
Kidney Blood Press Res; 2012; 35(6):504-10. PubMed ID: 22813903
[TBL] [Abstract][Full Text] [Related]
12. Extra-high dose hepatitis B vaccination for peritoneal dialysis patients: a randomised controlled trial.
Chow KM; Lo SH; Szeto CC; Yuen SK; Wong KS; Kwan BC; Leung CB; Li PK
Hong Kong Med J; 2012 Dec; 18 Suppl 6():41-3. PubMed ID: 23249854
[No Abstract] [Full Text] [Related]
13. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature.
Alavian SM; Tabatabaei SV
Vaccine; 2010 May; 28(22):3773-7. PubMed ID: 20371390
[TBL] [Abstract][Full Text] [Related]
14. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study.
Mettang T; Schenk U; Thomas S; Machleidt C; Kiefer T; Fischer FP; Kuhlmann U
Nephron; 1996; 72(2):192-6. PubMed ID: 8684526
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
Fabrizi F; Dixit V; Magnini M; Elli A; Martin P
Aliment Pharmacol Ther; 2006 Aug; 24(3):497-506. PubMed ID: 16886915
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review.
Cordova E; Miglia I; Festuccia F; Sarlo MG; Scornavacca G; Punzo G; Menè P; Fofi C
Ann Ig; 2017; 29(1):27-37. PubMed ID: 28067935
[TBL] [Abstract][Full Text] [Related]
18. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin.
Steketee RW; Ziarnik ME; Davis JP
Am J Epidemiol; 1988 Apr; 127(4):772-82. PubMed ID: 2965510
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients.
Beran J
Expert Opin Biol Ther; 2008 Feb; 8(2):235-47. PubMed ID: 18194079
[TBL] [Abstract][Full Text] [Related]
20. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
